Targeted hyperthermia-induced cancer cell death by superparamagnetic iron oxide nanoparticles conjugated to luteinizing hormone-releasing hormone

Nanotechnology Reviews

Volumn 3, Issue 4, 2014, Pages 389-400

  Mohammad, Faruq ^a   Raghavamenon, Achuthan C ^a   Claville, Michelle O ^b   Kumar, Challa S S R ^c   Uppu, Rao M ^a  

^a SOUTHERN UNIVERSITY   (United States)

^b HAMPTON UNIVERSITY   (United States)

^c LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

Heat shock proteins; Mitochondrial transmembrane potential; Nanomedicine; Nanoparticles; Role of caspases; Selective tumoricidal

Indexed keywords

BIOELECTRIC POTENTIALS; CELL DEATH; CYTOTOXICITY; GOLD COATINGS; IRON OXIDES; MAGNETIC FIELDS; MEDICAL NANOTECHNOLOGY; NANOPARTICLES; NEURONS; PROTEINS;

CASPASES; EXTERNAL MAGNETIC FIELD; HEAT SHOCK PROTEIN; LUTEINIZING HORMONE RELEASING HORMONES; MAGNETIC NANO-PARTICLES; MITOCHONDRIAL TRANSMEMBRANE POTENTIALS; SELECTIVE TUMORICIDAL; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES;

NANOMAGNETICS;

EID: 84904747438     PISSN: 21919089     EISSN: 21919097     Source Type: Journal    
DOI: 10.1515/ntrev-2013-0041     Document Type: Article

References (29)

1. Baronzio GF, Hager ED, Eds. Hyperthermia in Cancer Treatment: A Primer, Springer: New York, 2006.
2. Field SB, Bleehen NM. Hyperthermia in the treatment of cancer. Cancer Treat. Rev. 1979, 6, 63-94.
3. Kumar CSSR, Mohammad F. Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery. Adv. Drug Del. Rev. 2011, 63, 789-808.
4. Leuchner C, Kumar CSSR, Hansel W, Soboyejo W, Zhou J, Hormes J. LHRH-conjugated magnetic iron oxide nanoparticles for detection of breast cancer metastases. Breast Cancer Res. Treat. 2006, 99, 163-176.
5. Ito A, Shinkai M, Honda H, Yoshikawa K, Saga S, Wakabayashi T, Yoshida J, Kobayashi T. Heat-shock protein 70 expression induces antitumor immunity during intracellular hyperthermia using magnetite nanoparticles. Cancer Immunol. Immun. 2003, 52, 80-88.
6. Suzuki M, Shinkai M, Honda H, Kobayashi T. Anticancer effect and immune induction by hyperthermia of malignant melanoma using magnetite cationic liposomes. Melanoma Res. 2003, 13, 129-135.
7. Wang A, Li S. Hydroxycamptothecin-loaded nanoparticles enhance target drug delivery and anticancer effect. BMC Biotechnol. 2008, 8, 1-7.
8. Li S, Wang A, Jiang W, Guan Z. Pharmacokinetic characteristics and anticancer effects of 5-fluorouracil loaded nanoparticles. BMC Cancer 2008, 8, 1-9.
9. Hwang HY, Kim IS, Kwon IC, Kim YH. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles. J. Control Release 2008, 128, 23-31.
10. Gill JC, Wadas B, Chen P, Portillo W, Reyna A, Jorgensen E, Mani S, Schwarting GA, Moenter SM, Tobet S, Kaiser UB. The gonadotropin-releasing hormone (GnRH) neuronal population is normal in size and distribution in GnRH-deficient and GnRH receptor-mutant hypogonadal mice. Endocrinology 2008, 49, 4596-4604.
11. Schwanzel-Fukuda M, Zheng LM, Bergen H, Weesner G, Pfaff DW. LHRH neurons: functions and development. Prog. Brain Res. 1992, 93, 189-203.
12. Chatzaki E, Bax CMR, Eidne KA, Anderson L, Grudzinskas JG, Gallagher CJ. The expression of gonadotropin-releasing hormone and its receptor in endometrial cancer and its relevance as an autocrine growth factor. Cancer Res. 1996, 56, 2059-2065.
13. Limonta P, Dondi D, Moretti RM, Fermo D, Garattini E, Motta M. Expression of luteinizing hormone-releasing hormone mRNA in the human prostatic cancer cell line LNCaP. J. Clin. Endocrinol. Metab. 1993, 76, 797-800.
14. Campbell RE, Gaidamaka G, Han SK, Herbison AE. Dendrodendritic bundling and shared synapses between gonadotropin-releasing hormone neurons. Proc. Natl. Acad. Sci. USA 2009, 106, 10835-10840.
15. Dharap SS, Minko T. Targeted proapoptotic LHRH-BH3 peptide. Pharm. Res. 2003, 20, 889-896.
16. Minko T, Dharap SS, Pakunlu RI, Wang Y. Molecular targeting of drug delivery system to cancer. Curr. Drug Targets. 2004, 5, 389-406.
17. Leuschner C, Kumar CSSR, Hansel W, Hormes J. Targeting breast cancer cells and their metastases through luteinizing hormone releasing hormone (LHRH) receptors using magnetic nanoparticles. J. Biomed. Nanotech. 2005, 1, 229-233.
18. Kumar CSSR, Mohammad F. Magnetic gold nanoshells: stepwise changing of magnetism through stepwise biofunctionalization. J. Phys. Chem. Lett. 2010, 1, 3141-3146.
19. Mohammad F, Balaji G, Weber A, Uppu RM, Kumar CSSR. Influence of gold nanoshell on hyperthermia of superparamagnetic iron oxide nanoparticles. J. Phys. Chem. C 2010, 114, 19194-19201.
20. Kim DH, Rozhkova EA, Ulasov IV, Bader SD, Rajh T, Lesniak MS, Novosad V. Biofunctionalized magnetic-vortex microdiscs for targeted cancer-cell destruction. Nat. Mater. 2010, 9, 165-171.
21. Sathishkumar K, Gao X, Raghavamenon AC, Parinandi N, Pryor WA, Uppu RM. Cholesterol secoaldehyde induces apoptosis in H9c2 cardiomyoblasts through reactive oxygen species involving mitochondrial and death receptor pathways. Free Radic. Biol. Med. 2009, 47, 548-558.
22. Sathishkumar K, Xi X, Martin R, Uppu RM. Cholesterol secoaldehyde, an ozonation product of cholesterol induces amyloid aggregation and apoptosis in murine GT1-7 hypothalamic neurons. J. Alzheimer's Dis. 2007, 11, 261-274.
23. Ouyang YB, Xu LJ, Sun YJ, Giffard RG. Overexpression of inducible heat shock protein 70 and its mutants in astrocytes is associated with maintenance of mitochondrial physiology during glucose deprivation stress. Cell Stress Chaperones 2006, 11, 180-186.
24. Subjeck JR, Sciandra JJ, Johnson RJ. Heat-shock proteins and thermotolerance: a comparison of induction kinetics. Br. J. Radiol. 1982, 55, 579-584.
25. Sun Y, Ouyang YB, Xu L, Chow AM, Anderson R, Hecker JG, Giffard RG. The carboxyl-terminal domain of inducible Hsp70 protects from ischemic injury in vivo and in vitro. J. Cereb. Blood Flow Mef. 2006, 26, 937-955.
26. Poe BS, O'Neill KL. Inhibition of protein synthesis sensitizes thermotolerant cells to heat shock induced apoptosis. Apoptosis 1997, 2, 510-517.
27. Ito A, Nakahara Y, Fujioka M, Kobayashi T, Takeda K, Nakashima I, Honda H. Complete regression of hereditary melanoma in a mouse model by repeated hyperthermia using magnetite cationic liposomes. Jpn. J. Hyperthermic Oncol. 2005, 21, 139-149.
28. Ito A, Honda H, Kobayashi T. Cancer immnotherapy based on intracellular hyperthermia using magnetite nanoparticles: a novel concept of "heat-controlled necrosis" with heat-shock protein expression. Cancer Immunol. Immunother. 2006, 55, 320-328.
29. Branca RT, Cleveland ZI, Fubara B, Kumar CSSR, Maronpot RR, Leuschner C, Warren WS, Driehuys B. Molecular MRI for sensitive and specific detection of lung metastases. Proc. Natl. Acad. Sci. USA 2010, 107, 3693-3697.